T-cell Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for T-cell Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase II study of single-agent lenalidomide in relapsed or refractory T-cell non-Hodgkin's lymphoma has been terminated; results posted in 2…
-
CLINICAL_TRIALS trial_result · 2010-07-09Clinical Trial Update: Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating the combination of vorinostat and bortezomib in relapsed or refractory T-cell non-Hodgkin lymphoma was terminated; …